0001209191-20-008053.txt : 20200210 0001209191-20-008053.hdr.sgml : 20200210 20200210175853 ACCESSION NUMBER: 0001209191-20-008053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200128 FILED AS OF DATE: 20200210 DATE AS OF CHANGE: 20200210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANIDO VICENTE JR CENTRAL INDEX KEY: 0001207633 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 20593224 MAIL ADDRESS: STREET 1: 1621 BAYSIDE DR CITY: CORONA DEL MAR STATE: CA ZIP: 92625 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4301 EMPEROR BOULEVARD STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: (919) 237-5300 MAIL ADDRESS: STREET 1: 4301 EMPEROR BOULEVARD STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-28 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001207633 ANIDO VICENTE JR C/O AERIE PHARMACEUTICALS, INC. 4301 EMPEROR BLVD., SUITE 400 DURHAM NC 27703 1 1 0 0 Chief Executive Officer Common Stock 2020-01-28 5 W 0 E 2250 0.00 A 10500 I Spouse IRA Common Stock 2020-02-06 4 A 0 28000 0.00 A 225631 D Stock Option (right to buy) 21.18 2020-02-06 4 A 0 125000 0.00 A 2030-02-06 Common Stock 125000 125000 D These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of February 6, 2020. This option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of February 6, 2020. /s/ John LaRocca, Attorney-in-Fact for Vicente Anido, Jr. 2020-02-10